Genoptix gains 13% on strong Q2 growth, raised full-year guidance
Shares of Genoptix Inc. (Nasdaq:GXDX) have gained 13% in pre-market trading today after the company reported solid earnings after Thursday’s close. For the quarter ended June 30, revenues were $27.8 million, up from $13.9 million in the year-ago quarter. Net income was $5.6 million, or $0.32 per share, compared with $3.8 million, or $0.03 a share, for the same period a year earlier. The Carlsbad, Calif.-based company increased its full-year guidance for revenues of $105 million to $108 million, up from $90 million to $95 million.
In today’s pre-market trading, shares of the laboratory service provider are at $33, up $3.85 from Thursday’s close. The stock has ranged from $20.41 to $37.88 during the past year.
For detailed price information and recent news stories about Genoptix Inc., click GXDX.
